Company Information
USD
42.41
- (3.7%)
NASDAQ:MRUS, MERUS N.V.
Industry: Biotechnology
End of Day: 12 May 2025 GMT-4
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
Address
Uppsalalaan 17
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Mark T. Iwicki
Director
Dr. Maxine Gowen,PhD
Director
Mr. Paolo Pucci
Director
Mr. Gregory D. Perry
CFO/Director/Vice Chairman of the Board
Dr. Anand Mehra, M.D.
Chairman of the Board/Director
Dr. Victor Sandor, M.D.
Director
Dr. Hui Liu, M.B.A.,PhD
Other Corporate Officer/Other Executive Officer
Dr. Sven Ante Lundberg, M.D.
CEO/Director/President
Mr. Peter B. Silverman, J.D.
COO/Executive VP/General Counsel
Mr. Len Kanavy
Director
Mr. Harry Shuman
Chief Accounting Officer
Mr. Andrew Joe
Chief Medical Officer
Ownership
Institution Holdings
COMMODORE CAPITAL LP
4,747,373 (8.202%)
Incyte Corp
4,004,544 (6.936%)
Deerfield Management Co
3,876,938 (6.698%)
Federated Hermes, Inc.
3,637,309 (6.300%)
Federated Hermes Inc
3,637,309 (6.284%)
Federated Global Investment Management Corp
3,601,223 (6.222%)
Federated
3,601,223 (6.222%)
Samlyn Capital, LLC
3,412,410 (5.896%)
BVF Partners LP
2,978,420 (5.159%)
Bvf Inc
2,752,420 (4.756%)
Funds Holdings
Federated Hermes Kaufmann Sm Cp Fd
2,176,101 (3.760%)
Federated Hermes Kaufmann Small Cap Grow
2,176,101 (3.760%)
Federated Hermes Kaufmann Growth
1,425,122 (2.462%)
Federated Hermes Kaufmann
1,425,122 (2.462%)
Franklin Biotechnology Discovery Fund
447,826 (0.774%)
iShares Biotechnology ETF
327,023 (0.565%)
Belfius Equities Cure
318,076 (0.550%)
Driehaus Small Cap Growth Fund
128,977 (0.223%)
Vanguard Health Care Index Fund
124,480 (0.215%)
Driehaus Micro Cap Growth
81,762 (0.141%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
